Class III · Low risk
Methotrexate Tablets
Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.
FDA drug recalls in 2023
Every FDA drug recall initiated in 2023, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,122 recalls, newest first.
Class II · Moderate risk
Oxybutynin Chloride Extended-Release Tablets USP 10 mg
Failed Dissolution Specifications
Class II · Moderate risk
HYDROmorphone in dextrose 5%
Lack of assurance of sterility:
Class II · Moderate risk
HYDROmorphone in 0.9% Sodium Chloride
Lack of assurance of sterility:
Class II · Moderate risk
HYDROmorphone in dextrose 5%
Lack of assurance of sterility:
Class II · Moderate risk
HYDROmorphone in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
HYDROmorphone in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
HYDROmorphone in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
succinylcholine
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in dextrose 5%
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL
Lack of assurance of sterility:
Class II · Moderate risk
midazolam in dextrose 5%
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium…
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium…
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility: